PUMA BIOTECHNOLOGY, INC. (PBYI) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-07-09

PUMA BIOTECHNOLOGY, INC. (PBYI) has filed 10 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-09. 2 Form 8-K material event filings were reported by PBYI in the last 90 days. 8 Form 144 notices of proposed sale were filed for PBYI stock. InsiderAlpha tracks every PBYI SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About PUMA BIOTECHNOLOGY, INC. (PBYI)

SEC CIK0001401667

90-Day SEC Filing Activity

Form 4 filings (90d)10
Form 8-K filings (90d)2
Form 144 notices (90d)8
Latest Form 4 filing2026-07-09

Recent PBYI Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
HUNT DOUGLAS MSee RemarksS — Open-market sale8.5K$8.26$70KSEC
AUERBACH ALAN HPresident and CEOS — Open-market sale44.1K$8.26$364KSEC
NOUGUES MAXIMO FChief Financial OfficerS — Open-market sale9.4K$8.26$78KSEC
Senderowicz AdrianDirectorS — Open-market sale27.0K$7.20$194KSEC
MOYES JAY MDirectorS — Open-market sale22.0K$7.22$159KSEC
Dorval AllisonDirectorS — Open-market sale11.6K$7.20$84KSEC
Stuglik Brian MDirectorS — Open-market sale8.1K$7.20$58KSEC
WILSON TROY EDWARDDirectorS — Open-market sale10.8K$7.20$78KSEC
MOYES JAY MDirectorA — Grant or award27.0K$0.00—SEC
Cesano AlessandraDirectorA — Grant or award27.0K$0.00—SEC
Dorval AllisonDirectorA — Grant or award27.0K$0.00—SEC
Senderowicz AdrianDirectorA — Grant or award27.0K$0.00—SEC
MILLER MICHAEL PATRICKDirectorA — Grant or award27.0K$0.00—SEC
WILSON TROY EDWARDDirectorA — Grant or award27.0K$0.00—SEC
Stuglik Brian MDirectorA — Grant or award27.0K$0.00—SEC

All transactions sourced from SEC EDGAR Form 4 filings for PUMA BIOTECHNOLOGY, INC. (PBYI). Updated in real time as new filings are submitted to the SEC.

Most-Active PBYI Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
Senderowicz Adrian2$194K
WILSON TROY EDWARD2$78K
Stuglik Brian M2$58K
Dorval Allison2$84K
MOYES JAY M2$159K

Recent PBYI Form 8-K Material Events

Recent PBYI Form 144 Notices of Proposed Sale

Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in PBYI insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

PBYI Insider Trading — FAQ

What is the latest insider trade for PBYI?
PUMA BIOTECHNOLOGY, INC. (PBYI) had 10 insider filings in the last 90 days, with the most recent on 2026-07-09. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying PBYI stock?
0 insider purchases of PBYI were filed in the last 90 days.
How many insiders are selling PBYI stock?
0 insider sales of PBYI were filed in the last 90 days.
Where can I see PBYI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every PBYI SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live PBYI dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.